Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China · Delayed Price · Currency is CNY 49.68
-0.47 (-0.94%)
May 12, 2026, 3:00 PM CST
SHA:603334 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 144.76 | 140.55 | 123.82 | 129.71 | 133.35 | 101.91 |
Depreciation & Amortization | 30.59 | 30.59 | 19.61 | 18.14 | 12.25 | 10.24 |
Other Amortization | 1.31 | 1.31 | 2.25 | 2.27 | 1.5 | 0.29 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.05 | -0.02 | 0.06 | 0.41 |
Asset Writedown & Restructuring Costs | 0.41 | 0.41 | 0.06 | 0.76 | 1.7 | 1.63 |
Loss (Gain) From Sale of Investments | -1.02 | -1.02 | -0.7 | 3.98 | 5.07 | - |
Provision & Write-off of Bad Debts | 2.8 | 2.8 | 4.56 | -3.17 | 1.9 | 2.11 |
Other Operating Activities | 121.6 | 10.73 | 2.68 | 10.88 | -2.86 | 3.12 |
Change in Accounts Receivable | -24.86 | -24.86 | -118.19 | 66.43 | -92.78 | -84.3 |
Change in Inventory | -283.21 | -283.21 | -44.27 | -96.73 | 13.55 | 9.96 |
Change in Accounts Payable | 103.51 | 103.51 | 32.81 | 1.47 | 36.21 | 41.85 |
Change in Other Net Operating Assets | -3.58 | -3.58 | 3.28 | 28.86 | -40.24 | -6.7 |
Operating Cash Flow | 88.64 | -26.44 | 22.43 | 162.5 | 69.72 | 76.95 |
Operating Cash Flow Growth | 129.07% | - | -86.20% | 133.07% | -9.40% | 2.77% |
Capital Expenditures | -28.46 | -24.36 | -79.53 | -168.11 | -80.1 | -71.94 |
Sale of Property, Plant & Equipment | 0.18 | 0.19 | 0.17 | 0.18 | 0.36 | 0.52 |
Investment in Securities | -130 | -300 | - | 0.18 | 0.02 | -2.3 |
Other Investing Activities | 1.7 | 0.9 | 0.44 | 0.34 | -7.42 | 1.31 |
Investing Cash Flow | -156.57 | -323.27 | -78.92 | -167.41 | -87.14 | -72.41 |
Short-Term Debt Issued | - | 28.61 | 7.34 | 0.48 | - | - |
Long-Term Debt Issued | - | 371.5 | 315.2 | 248.98 | 328.57 | 164.9 |
Total Debt Issued | 291.11 | 400.11 | 322.54 | 249.46 | 328.57 | 164.9 |
Long-Term Debt Repaid | - | -438.99 | -247 | -250.29 | -221.16 | -124.9 |
Net Debt Issued (Repaid) | -173.18 | -38.88 | 75.54 | -0.83 | 107.4 | 40 |
Issuance of Common Stock | 795.44 | 795.44 | - | - | 14.1 | - |
Common Dividends Paid | -9.46 | -10.35 | -10.63 | -25.37 | -22 | -3.87 |
Other Financing Activities | 0.6 | - | - | - | -1.49 | -0.34 |
Financing Cash Flow | 613.39 | 746.21 | 64.91 | -26.2 | 98.01 | 35.79 |
Foreign Exchange Rate Adjustments | -3.75 | -0.1 | 4.65 | 2.94 | 10.34 | -1.86 |
Net Cash Flow | 541.71 | 396.4 | 13.07 | -28.18 | 90.93 | 38.47 |
Free Cash Flow | 60.18 | -50.8 | -57.1 | -5.62 | -10.38 | 5.01 |
Free Cash Flow Growth | - | - | - | - | - | -91.49% |
Free Cash Flow Margin | 1.67% | -1.60% | -2.93% | -0.33% | -0.61% | 0.39% |
Free Cash Flow Per Share | 0.49 | -0.45 | -0.53 | -0.05 | -0.10 | 0.05 |
Cash Income Tax Paid | 88.81 | 67.5 | -10.36 | 48.84 | 43.27 | 41.59 |
Levered Free Cash Flow | 11.82 | -104.73 | -148.93 | -84.83 | 48.87 | 1.9 |
Unlevered Free Cash Flow | 16.63 | -99.92 | -145.18 | -80.38 | 52.8 | 3.99 |
Change in Working Capital | -211.78 | -211.78 | -129.79 | -0.07 | -83.25 | -42.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.